;

AI Health Law & Policy Summit 2026

Thought Leadership

2026 Life Sciences & Health Care Horizons

CMS Health Tech Ecosystem moves from vision to deployment

FDA seeks input on real-time clinical trials pilot, AI use in studies

EU Rethinks How to Regulate AI in Medical Devices – Interplay between the MDR and AIA under current and proposed legislation

Medical devices incorporating AI – Navigating roles and responsibilities of manufacturers/providers and users/deployers under the MDR and AIA

Practical considerations for using AI in analyzing clinical data and preparing FDA submissions

The concept of human oversight over AI in medical devices

“Hogan Lovells” or the “firm” is an international legal practice that includes Hogan Lovells International LLP, Hogan Lovells US LLP and their affiliated businesses.

The word “partner” is used to describe a partner or member of Hogan Lovells International LLP, Hogan Lovells US LLP or any of their affiliated entities or any employee or consultant with equivalent standing. Certain individuals, who are designated as partners, but who are not members of Hogan Lovells International LLP, do not hold qualifications equivalent to members.

For more information about Hogan Lovells, the partners and their qualifications, see www.hoganlovells.com.

Where case studies are included, results achieved do not guarantee similar outcomes for other clients. Attorney advertising. Images of people may feature current or former lawyers and employees at Hogan Lovells or models not connectedwith the firm.